Bukwang Pharm Cash Flow Quality Index
Bukwang Pharm cash flow quality index. Bukwang Pharm (003000) has a Cash Flow Quality Index of -4.08x as of September 2025. Operating cash flow of ₩-6.24 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. See 003000 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Bukwang Pharm (2007–2018)
Cash flow quality index of Bukwang Pharm from 2007 to 2018. Historical Cash Flow Quality Index for Bukwang Pharm across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Bukwang Pharm (003000) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Bukwang Pharm Cash Flow Quality Index by Year (2007–2018)
Bukwang Pharm cash flow quality index by year from 2007 to 2018. Year-by-year earnings quality comparison for Bukwang Pharm. For the full cash flow conversion analysis, see Bukwang Pharm cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 0.05x | ₩6.82 Billion | ₩145.67 Billion | ▼ -93.9% |
| 2017 | 0.77x | ₩8.56 Billion | ₩11.09 Billion | ▲ +257.2% |
| 2016 | -0.49x | ₩-7.76 Billion | ₩15.81 Billion | ▼ -219.9% |
| 2015 | 0.41x | ₩10.30 Billion | ₩25.14 Billion | ▼ -65.3% |
| 2014 | 1.18x | ₩27.86 Billion | ₩23.62 Billion | ▼ -36.9% |
| 2013 | 1.87x | ₩36.52 Billion | ₩19.53 Billion | ▲ +120.1% |
| 2007 | 0.85x | ₩27.87 Billion | ₩32.82 Billion | — |